The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury

Brain

Volumn 132, Issue 8, 2009, Pages 2206-2218

  Ceruti, Stefania ^a,b   Villa, Giovanni ^a,b   Genovese, Tiziana ^b,c   Mazzon, Emanuela ^b,c   Longhi, Renato ^d   Rosa, Patrizia ^d   Bramanti, Placido ^b   Cuzzocrea, Salvatore ^b,c   Abbracchio, Maria P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d CNR   (Italy)

Author keywords

Antisense oligonucleotides; Ependymal cells; GPR17; Precursor cells; Spinal cord injury

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; BROXURIDINE; CELL MARKER; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR GPR 17; GLIAL FIBRILLARY ACIDIC PROTEIN; LEUKOTRIENE C4; LEUKOTRIENE D4; NESTIN; PURINERGIC P2Y12 RECEPTOR; PYRIMIDINE NUCLEOTIDE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPENDYMA CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION; MALE; MICROGLIA; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SPINAL CORD INJURY;

ANIMALS; BIOLOGICAL MARKERS; CELL MOVEMENT; CELL PROLIFERATION; EPENDYMA; GENE KNOCKDOWN TECHNIQUES; MACROPHAGES; MALE; MICE; MICE, INBRED STRAINS; MICROGLIA; MOVEMENT DISORDERS; NERVE TISSUE PROTEINS; NEURONS; OLIGODENDROGLIA; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PLURIPOTENT STEM CELLS; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD; SPINAL CORD INJURIES;

EID: 67749129263     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp147     Document Type: Article

References (46)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006; 58: 281-341.
2. Abbracchio MP, Ceruti S. Roles of P2 receptors in glial cells: focus on astrocytes. Purinergic Signal 2006; 2: 595-604.
3. Bao F, DeWitt DS, Prough DS, Liu D. Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: reduction by Mn (III) tetrakis (4-benzoic acid) porphyrin. J Neurosci Res 2003; 71: 220-7.
4. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
5. Blasius R, Weber RG, Lichter P, Ogilvie A. A novel orphan G protein-coupled receptor primarily expressed in the brain is localized on human chromosomal band 2q21. J Neurochem 1998; 70: 1357-65.
6. Blight AR. Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience 1983; 10: 521-43.
7. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 1998; 89: 699-706.
8. Buffo A, Rite I, Tripathi P, Lepier A, Colak D, Horn AP, et al. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain. Proc Natl Acad Sci USA 2008; 105: 3581-6.
9. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004; 240: 31-304.
10. Carlén M, Meletis K, Gö ritz C, Darsalia V, Evergren E, Tanigaki K, et al. Forebrain ependymal cells are Notch-dependent and generate neuroblasts and astrocytes after stroke. Nat Neurosci 2009; 12: 259-67.
11. Ciana P, Fumagalli M, Trincavelli ML, Verderio C, Rosa P, Lecca D, et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/ cysteinyl-leukotrienes receptor. EMBO J 2006; 25: 4615-27.
12. Ciceri P, Rabuffetti M, Monopoli A, Nicosia S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol 2001; 133: 1323-9.
13. Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, et al. Glycogen synthase kinase-3 beta inhibition reduces secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 2006; 318: 79-89.
14. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8: 752-8.
15. de Castro F, Bribian A. The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev 2005; 49: 227-41.
16. Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP. Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 2009; 32: 79-87.
17. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, et al. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006; 176: 3877-83.
18. Franke H, Krü gel U, Illes P. P2 receptors and neuronal injury. Pflugers Arch Eur J Physiol 2006; 452: 622-44.
19. Genovese T, Mazzon E, Mariotto S, Menegazzi M, Cardali S, Conti A, et al. Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine 2006; 4: 145-53.
20. Genovese T, Mazzon E, Crisafulli C, Esposito E, Di Paola R, Muia C, et al. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007; 150: 168-81.
21. Genovese T, Esposito E, Mazzon E, Muia C, Di Paola R, Meli R, et al. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther 2008a; 325: 100-14.
22. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, Esposito E, et al. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008b; 29: 32-41.
23. Genovese T, Rossi A, Mazzon E, Di Paola R, Muia C, Caminiti R, et al. Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol 2008c; 153: 568-82.
24. Glaser J, Gonzalez R, Sadr E, Keirstead HS. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury. J Neurosci Res 2006; 84: 724-34.
25. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006; 9: 1512-9.
26. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT. Omega-3 fatty acids improve recovery, whereas Omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 2006; 26: 4672-80.
27. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007; 446: 1091-5.
28. Kozlova EN. Differentiation and migration of astrocytes in the spinal cord following dorsal root injury in the adult rat. Eur J Neurosci 2003; 17: 782-90.
29. Kulbatski I, Mothe AJ, Nomura H, Tator CH. Endogenous and exogenous CNS derived stem/progenitor cell approaches for neurotrauma. Curr Drug Targets 2005; 6: 111-26.
30. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004; 4: 451-64.
31. Lecca D, Ceruti S. Uracil nucleotides: from metabolic intermediates to neuroprotection and neuroinflammation. Biochem Pharmacol 2008; 75: 1869-81.
32. Lecca D, Trincavelli ML, Gelosa P, Sironi L, Ciana P, Fumagalli M, et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS One 2008; 3: e3579.
33. Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev 2002; 39: 55-73.
34. Maisel M, Herr A, Milosevic J, Hermann A, Habisch HJ, Schwarz S, et al. Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells 2007; 25: 1231-40.
35. Marchetti B, Abbracchio MP. To be or not to be (inflamed) - is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? Trends Pharmacol Sci 2005; 26: 517-25.
36. Meletis K, Barnabe-Heider F, Carlen M, Evergren E, Tomilin N, Shupliakov O, et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol 2008; 6: e182.
37. Mothe AJ, Tator CH. Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience 2005; 131: 177-87.
38. Nishisho T, Tonai T, Tamura Y, Ikata T. Experimental and clinical studies of eicosanoids in cerebrospinal fluid after spinal cord injury. Neurosurgery 1996; 39: 950-6; discussion 956-7.
39. Parravicini C, Ranghino G, Abbracchio MP, Fantucci P. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors. BMC Bioinformatics 2008; 9: 263.
40. Raport CJ, Schweickart VL, Chantry D, Eddy RL Jr, Shows TB, Godiska R, et al. New members of the chemokine receptor gene family. J Leukoc Biol 1996; 59: 18-23.
41. Samadikuchaksaraei A. An overview of tissue engineering approaches for management of spinal cord injuries. J Neuroeng Rehabil 2007; 4: 15.
42. Samuelsson B. The discovery of the leukotrienes. Am J Respir Crit Care Med 2000; 161: S2-6.
43. Stirling DP, Yong VW. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 2008; 86: 1944-58.
44. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 2004; 10: 821-7.
45. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord 2006; 44: 523-9.
46. Zai LJ, Wrathall JR. Cell proliferation and replacement following contusive spinal cord injury. Glia 2005; 50: 247-57.